-
Updated Projections of HPV Vaccine Coverage Growth in Europe: Are Countries on Track to Meet WHO's 2030 Target?
Sep 9, 2025, 16:22 PM -
Biomarker Levels in Patients With Crohn’s Disease Post-Advanced Therapy Induction: A Real-World Survey in Europe
Sep 9, 2025, 16:22 PM -
Out-of-Work Transitions in the European Population With Noncommunicable Diseases
Sep 9, 2025, 16:22 PM -
Stop Ignoring Missing Patients the Hidden Impact of Ignoring Missing Data in Health State Utility Estimation
Sep 9, 2025, 16:22 PM -
Use of Encorafenib + Cetuximab EC in Patients With BRAF V600E–Mutant Metastatic Colorectal Cancer (mCRC) in Real-World Settings: Data Visualization From a Pooled Dataset of European Observational Studies
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Epigenetic Drugs in Oncology: A Systematic Review of Economic Evaluations
Sep 9, 2025, 16:22 PM -
Real-World Patient Characteristics and Outcomes Associated With Antibody Drug Conjugate Therapy: A Large Cohort Study
Sep 9, 2025, 16:22 PM -
Preventing Stunting Through Early Nutritional Intervention: Effectiveness and Economic Evaluation in Children With Weight Faltering
Sep 9, 2025, 16:22 PM -
Synthesizing Health Service Utilization Data for a Complex Intervention: A Case Study of Teledermatology
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis of Transcatheter Valve Replacement Using Valves With RESILIA Tissue for the Treatment of Aortic Stenosis in South Korea
Sep 9, 2025, 16:22 PM -
Sex Differences in Autoimmune Multimorbidity Across 11 Autoimmune Disorders in the Real-World Setting in Germany
Sep 9, 2025, 16:22 PM -
Conceptualizing an Economic Model Structure for Parkinson's Disease
Sep 9, 2025, 16:22 PM -
Insights From a French Postmarketing Authorization Early Access (MA EA) Mechanism: Projecting Clinical and Economic Benefits of Neoadjuvant Nivolumab–Platinum-Based Chemotherapy (PDC) in Resectable Non-Small Cell Lung Cancer
Sep 9, 2025, 16:22 PM -
Patient-Reported Stigma Across Health Conditions: Insights From the National Health and Wellness Survey (NHWS) in China
Sep 9, 2025, 16:22 PM -
Cost Analysis of Polatuzumab Vedotin in Combination With Rituximab Cyclophosphamide Doxorubicin and Prednisone in the Treatment of Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma in Portugal
Sep 9, 2025, 16:22 PM -
A Scoping Review of Resource Modeling in HTA Using Discrete Event Simulation
Sep 9, 2025, 16:22 PM -
Advancing the Science of Qualitative Patient Preference Assessment Using Large Language Models
Sep 9, 2025, 16:22 PM -
Using Natural Language Processing to Identify Sequencing Patterns in Advanced Urothelial Carcinoma: A Real-World Observational Study
Sep 9, 2025, 16:22 PM -
Impact of Glucagon-Like Peptide-1 Treatments on Patient-Reported Outcomes in Type 2 Diabetes Mellitus
Sep 9, 2025, 16:22 PM -
Comparing Alternative Extrapolation Methods Using Standard Partitioned Survival Model Functionality in the Presence of Converging Survival Data: A Case Study in Renal Cell Carcinoma
Sep 9, 2025, 16:22 PM
